Treatment with antioxidants ameliorates oxidative damage in a mouse model of propionic acidemia.

TitleTreatment with antioxidants ameliorates oxidative damage in a mouse model of propionic acidemia.
Publication TypeJournal Article
Year of Publication2017
AuthorsRivera-Barahona, A, Alonso-Barroso, E, Pérez, B, Murphy, MP, Richard, E, Desviat, LR
JournalMol Genet Metab
Volume122
Issue1-2
Pagination43-50
Date Published2017 Sep
ISSN1096-7206
Abstract

Oxidative stress contributes to the pathogenesis of propionic acidemia (PA), a life threatening disease caused by the deficiency of propionyl CoA-carboxylase, in the catabolic pathway of branched-chain amino acids, odd-number chain fatty acids and cholesterol. Patients develop multisystemic complications including seizures, extrapyramidal symptoms, basal ganglia deterioration, pancreatitis and cardiomyopathy. The accumulation of toxic metabolites results in mitochondrial dysfunction, increased reactive oxygen species and oxidative damage, all of which have been documented in patients' samples and in a hypomorphic mouse model. Here we set out to investigate whether treatment with a mitochondria-targeted antioxidant, MitoQ, or with the natural polyphenol resveratrol, which is reported to have antioxidant and mitochondrial activation properties, could ameliorate the altered redox status and its functional consequences in the PA mouse model. The results show that oral treatment with MitoQ or resveratrol decreases lipid peroxidation and the expression levels of DNA repair enzyme OGG1 in PA mouse liver, as well as inducing tissue-specific changes in the expression of antioxidant enzymes. Notably, treatment decreased the cardiac hypertrophy marker BNP that is found upregulated in the PA mouse heart. Overall, the results provide in vivo evidence to justify more in depth investigations of antioxidants as adjuvant therapy in PA.

DOI10.1016/j.ymgme.2017.07.009
Alternate JournalMol. Genet. Metab.
Citation Key10.1016/j.ymgme.2017.07.009
PubMed ID28774709